๐๐๐ฒ ๐๐!โ
Behind door 22 we find Novartis in the CB European Quality Fund and American Water in the CB Save Earth Fund.
๐๐จ๐ฏ๐๐ซ๐ญ๐ข๐ฌ โ Swiss pharmaceutical giant focused on innovative specialty medicines.
โญ ๐๐๐๐ข๐ง๐๐ ๐ข๐ง๐ง๐จ๐ฏ๐๐ญ๐ข๐จ๐ง: A strong focus on patented medicines within radioligand therapy, gene therapy, and cell therapy has given Novartis a strong market position with high barriers to entry.
โญ ๐๐๐ฒ ๐ฉ๐ซ๐จ๐๐ฎ๐๐ญ๐ฌ: The portfolio is driven by blockbuster drugs such as Entresto (cardiovascular), Cosentyx (immunology), Kesimpta (MS), as well as oncology successes Kisqali and Pluvicto.
๐ฑ The company works in line with the UN Sustainable Development Goals and has set SBTi-validated COโ reduction targets.
๐๐ฆ๐๐ซ๐ข๐๐๐ง ๐๐๐ญ๐๐ซ ๐๐จ๐ซ๐ค๐ฌ โ the largest publicly listed water utility company in the United States.
โญ ๐๐จ๐ง๐ฌ๐จ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง ๐ฌ๐ญ๐ซ๐๐ญ๐๐ ๐ฒ: Drives growth through an active M&A strategy, acquiring and modernising underinvested municipal water systems.
โญ ๐๐ซ๐ข๐ญ๐ข๐๐๐ฅ ๐ข๐ง๐๐ซ๐๐ฌ๐ญ๐ซ๐ฎ๐๐ญ๐ฎ๐ซ๐: Provides essential public infrastructure under regulated frameworks, offering high stability and protection against economic cycles.
๐ฑ The company works with several of the 17 UN Sustainable Development Goals, with a particular focus on Goal 6: Clean Water and Sanitation for All.
This communication should not be considered financial advice but marketing material. Please note that all investments involve risk. Fund unit prices may rise or fall, and investments are always subject to the risk of loss. Historical performance is never a guarantee of future returns. Please note that the companies were included in the respective fund portfolios as of 22 December. The companies may, in theory, have exited the portfolios at the time of publication of this specific calendar entry.